Sio Gene Therapies Insiders
SIOXDelisted Stock | USD 0.40 0.01 2.56% |
Sio Gene employs about 12 people. The company is managed by 3 executives with a total tenure of roughly 28 years, averaging almost 9.0 years of service per executive, having 4.0 employees per reported executive. Break down of Sio Gene's management performance can provide insight into the company performance.
Sio |
Sio Gene Management Team Effectiveness
The company has return on total asset (ROA) of (0.2434) % which means that it has lost $0.2434 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.475) %, meaning that it created substantial loss on money invested by shareholders. Sio Gene's management efficiency ratios could be used to measure how well Sio Gene manages its routine affairs as well as how well it operates its assets and liabilities.Sio Gene Workforce Comparison
Sio Gene Therapies is currently regarded as top stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 1,156. Sio Gene claims roughly 12.0 in number of employees contributing just under 2% to stocks in Biotechnology industry.
Sio Gene Notable Stakeholders
A Sio Gene stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sio Gene often face trade-offs trying to please all of them. Sio Gene's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sio Gene's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Raquel Crystal | Head Operations | Profile | |
David JD | CFO, CEO | Profile | |
Guangping Gao | Chief Advisor | Profile |
About Sio Gene Management Performance
The success or failure of an entity such as Sio Gene Therapies often depends on how effective the management is. Sio Gene management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sio management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sio management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York. Sio Gene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.
Please note, the imprecision that can be found in Sio Gene's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Sio Gene Therapies. Check Sio Gene's Beneish M Score to see the likelihood of Sio Gene's management manipulating its earnings.
Sio Gene Workforce Analysis
Traditionally, organizations such as Sio Gene use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sio Gene within its industry.Sio Gene Manpower Efficiency
Return on Sio Gene Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 6M | |
Net Loss Per Executive | 24M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Sio Stock
If you are still planning to invest in Sio Gene Therapies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sio Gene's history and understand the potential risks before investing.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Transaction History View history of all your transactions and understand their impact on performance |